Focal Takotsubo Cardiomyopathy With High-Dose Interleukin-2 Therapy for Malignant Melanoma

被引：10
|
作者：
Damodaran, Senthil [1 ]
Mrozek, Ewa [1 ]
Liebner, David [1 ]
Kendra, Kari [1 ]
机构：
[1] Ohio State Univ, Wexner Med Ctr, Div Med Oncol, Columbus, OH 43210 USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2014年 / 12卷 / 12期
关键词：
REVERSIBLE CARDIOMYOPATHY; METASTATIC MELANOMA;
D O I：
10.6004/jnccn.2014.0168
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
High-dose interleukin-2 (IL-2) is an available treatment option for patients with metastatic melanoma or renal cell carcinoma, and is associated with sustained complete and partial responses in a subset of patients. IL-2, however, is not devoid of toxicities, most of which involve the cardiovascular system and manifest as hypotension, arrhythmias, and cardiomyopathy. This report describes an unusual presentation of takotsubo cardiomyopathy in a postmenopausal woman receiving high-dose IL-2 for metastatic melanoma.
引用
收藏
页码：1666 / 1670
页数：5
相关论文
共 50 条
  • [1] CARDIOMYOPATHY ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY
    BECK, AC
    WARD, JH
    HAMMOND, EH
    WRAY, RB
    SAMLOWSKI, WE
    WESTERN JOURNAL OF MEDICINE, 1991, 155 (03): : 293 - 296
  • [2] REVERSIBLE CARDIOMYOPATHY AFTER HIGH-DOSE INTERLEUKIN-2 THERAPY
    GOEL, M
    FLAHERTY, L
    LAVINE, S
    REDMAN, BG
    JOURNAL OF IMMUNOTHERAPY, 1992, 11 (03): : 225 - 229
  • [3] High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
    Silk, Ann W.
    Kaufman, Howard L.
    Curti, Brendan
    Mehnert, Janice M.
    Margolin, Kim
    McDermott, David
    Clark, Joseph
    Newman, Jenna
    Bommareddy, Praveen K.
    Denzin, Lisa
    Najmi, Saltanat
    Haider, Azra
    Shih, Weichung
    Kane, Michael P.
    Zloza, Andrew
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [4] Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma
    Thavendiranathan, P.
    Verhaert, D.
    Kendra, K. L.
    Raman, S. V.
    BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1001): : E99 - E102
  • [5] Bolus high dose interleukin-2 for the treatment of malignant melanoma
    Pappo, I
    Lotem, M
    Klein, M
    Orda, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (03): : 169 - 173
  • [6] Bolus high dose interleukin-2 for the treatment of malignant melanoma
    Pappo, I. (pappo@cc.huji.ac.il), 2001, Israel Medical Association (03):
  • [7] High Dose Inhalation Interleukin-2 Therapy for Lung Metastases in Patients with Malignant Melanoma
    Weihsengruber, F.
    Bartsch, K.
    Rappersberger, K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 (09): : 837 - 837
  • [8] High Dose Inhalation Interleukin-2 Therapy for Lung Metastases in Patients with Malignant Melanoma
    Bartsch, K.
    Weihsengruber, F.
    Rappersberger, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S29 - S29
  • [9] High dose inhalation interleukin-2 therapy for lung metastases in patients with malignant melanoma
    Enk, AH
    Nashan, D
    Rübben, A
    Knop, J
    CANCER, 2000, 88 (09) : 2042 - 2046
  • [10] ACUTE-PANCREATITIS ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 IMMUNOTHERAPY FOR MALIGNANT-MELANOMA
    BIRCHFIELD, GR
    WARD, JH
    REDMAN, BG
    FLAHERTY, L
    SAMLOWSKI, WE
    WESTERN JOURNAL OF MEDICINE, 1990, 152 (06): : 714 - 716
12345